Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [¹⁸F]-Fluorodeoxyglucose Positron Emission Tomography Study.

ABSTRACT: Introduction: Long-term consequences of medicinal cannabis use in people with multiple sclerosis (PwMS) are unknown. This study investigated whether PwMS using cannabis had lower resting brain glucose uptake (GU) and worse clinical test results compared with nonusers. Methods: Sixteen PwMS, eight users, underwent clinical testing followed by [¹⁸F]-Fluorodeoxyglucose positron emission tomography/computed tomography imaging. Results: Users had lower cognitive function test scores, but performed similarly on the other clinical evaluations. Accounting for disease duration, resting brain GU was similar between the groups. Conclusions: Lower cognitive function was not associated with resting brain GU. Cognitive dysfunction may be a contraindication or conse

SUBMITTER: Kindred JH 

PROVIDER: S-EPMC6186162 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature